Glencoe, MO, United States of America

John P Mc Kearn


Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John P Mc Kearn: Innovator in Hematopoietic Receptor Agonists

Introduction

John P Mc Kearn is a notable inventor based in Glencoe, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of multi-functional chimeric hematopoietic receptor agonists. With a total of 2 patents, his work has the potential to impact therapeutic approaches in various medical applications.

Latest Patents

Among his latest patents, the first is titled "Multi-functional chimeric hematopoietic receptor agonists." This patent discloses novel multi-functional chimeric hematopoietic receptor agonist proteins, along with the DNAs that encode these proteins. It also outlines methods for making and using these proteins. The second patent, "Circular permuteins of flt3 ligand," presents novel flt-3 receptor agonist proteins and the corresponding DNAs. This patent details methods for creating and utilizing these receptor agonist proteins.

Career Highlights

Throughout his career, John P Mc Kearn has worked with prominent organizations, including Pharmacia Corporation. His experience in the industry has allowed him to develop innovative solutions that address complex biological challenges.

Collaborations

John has collaborated with esteemed colleagues such as Charles A McWherter and Yiqing Feng. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

John P Mc Kearn stands out as an influential inventor in the realm of hematopoietic receptor agonists. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…